0001179110-15-007645.txt : 20150512 0001179110-15-007645.hdr.sgml : 20150512 20150512173014 ACCESSION NUMBER: 0001179110-15-007645 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150508 FILED AS OF DATE: 20150512 DATE AS OF CHANGE: 20150512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weber David M CENTRAL INDEX KEY: 0001399519 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 15855622 BUSINESS ADDRESS: BUSINESS PHONE: 925-600-8826 MAIL ADDRESS: STREET 1: 2341 ROMANO CIRCLE CITY: PLEASANTON STATE: CA ZIP: 94566 4 1 edgar.xml FORM 4 - X0306 4 2015-05-08 0 0000815094 ABIOMED INC ABMD 0001399519 Weber David M C/O ABIOMED, INC. 22 CHERRY HILL DRIVE DANVERS MA 01923 0 1 0 0 Chief Operating Officer Common Stock, $.01 par value 2015-05-08 4 M 0 34322 13.88 A 171052 D Common Stock, $.01 par value 2015-05-08 4 S 0 3242 64.1598 D 167810 D Common Stock, $.01 par value 2015-05-08 4 S 0 3639 65.1294 D 164171 D Common Stock, $.01 par value 2015-05-08 4 S 0 1911 66.3305 D 162260 D Common Stock, $.01 par value 2015-05-08 4 S 0 4880 67.3336 D 157380 D Common Stock, $.01 par value 2015-05-08 4 S 0 2764 67.8776 D 154616 D Common Stock, $.01 par value 2015-05-08 4 S 0 652 69.0306 D 153964 D Common Stock, $.01 par value 2015-05-08 4 S 0 73 69.81 D 153891 D Common Stock, $.01 par value 2015-05-08 4 S 0 3242 64.1598 D 150649 D Common Stock, $.01 par value 2015-05-08 4 S 0 3639 65.1294 D 147010 D Common Stock, $.01 par value 2015-05-08 4 S 0 1911 66.3305 D 145099 D Common Stock, $.01 par value 2015-05-08 4 S 0 4880 67.3336 D 140219 D Common Stock, $.01 par value 2015-05-08 4 S 0 2764 67.8776 D 137455 D Common Stock, $.01 par value 2015-05-08 4 S 0 652 69.0306 D 136803 D Common Stock, $.01 par value 2015-05-08 4 S 0 73 69.81 D 136730 D Stock Option (right to buy) 13.88 2015-05-08 4 M 0 34322 0 D 2008-04-23 2017-04-23 Common Stock 34322 40000 D Stock Option (right to buy) 13.80 2009-05-23 2018-05-23 Common Stock 0 12000 D Stock Option (right to buy) 5.86 2010-05-28 2019-05-28 Common Stock 0 51000 D Stock Options (right to buy) 5.86 2010-03-31 2019-05-28 Common Stock 0 34500 D Stock Option (right to buy) 10.03 2011-06-03 2020-06-03 Common Stock 0 50000 D Stock Option (right to buy) 22.44 2013-05-22 2022-05-22 Common Stock 0 25000 D Stock Option (Right to Buy) 23.15 2014-05-14 2023-05-14 Common Stock 0 23000 D Stock Option (Right to Buy) 21.55 2015-05-14 2024-05-14 Common Stock 0 15000 D Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan. This option becomes exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6. Sale of common stock pursuant to reporting owner's 10b5-1 plan. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $63.6200 and $64.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $64.6200 and $65.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $65.6750 and $66.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $66.7000 and $67.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.7000 and $68.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.7000 and $69.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.7000 and $69.9600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. To remedy a broker error that occurred in connection with executing the transaction, in accordance with the broker's policy, the reporting person received from the broker an additional payment for the sale of the shares to make the average price per share $67.0000. To remedy a broker error that occurred in connection with executing the transaction, in accordance with the broker's policy, the reporting person received from the broker an additional payment for the sale of the shares sold below $67.0000 per share to make the price per share of such shares $67.0000 per share. /s/ Stephen C. McEvoy (by power of attorney) 2015-05-12 EX-24 2 ex24weber.txt LIMITED POWER OF ATTORNEY The undersigned does hereby appoint each of Stephen C. McEvoy, Ian W. McLeod, and Loretta Wedge, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director or officer of ABIOMED, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in- fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, this power of attorney has been executed as of the 29th day of May, 2009 and shall remain in full force and effect until withdrawn by the undersigned in writing. Signature: /s/ David M Weber Print Name: David M Weber